Price
Target price
€60.94
€60.94
-3.200%
-2.02
-3.200%
€93.73
18.07.25 / Tradegate
WKN: 529882 / Symbol: CORT / Name: Corcept / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
Corcept Therapeutics Inc. Stock
Corcept Therapeutics Inc. took a tumble today and lost -€2.020 (-3.200%).
Corcept Therapeutics Inc. is currently one of the favorites of our community with 15 Buy predictions and no Sell predictions.
As a result the target price of 93 € shows a very positive potential of 52.61% compared to the current price of 60.94 € for Corcept Therapeutics Inc..
For the coming years our community has positive and negative things to say abot the Corcept Therapeutics Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Corcept Therapeutics Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
C******** o* t** e**********
Cons
?
M***** P*******
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Corcept Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Corcept Therapeutics Inc. | -3.200% | -0.975% | -1.805% | 99.281% | 22.345% | 129.962% | 323.194% |
| Rockwell Medical Inc. | 1.310% | -14.418% | 16.551% | -47.356% | -54.067% | -19.478% | -95.271% |
| Pacira Pharmaceuticals | -1.570% | -5.528% | -9.615% | -1.053% | 1.622% | -63.846% | -60.504% |
| Twist Bioscience Corp | -2.810% | -7.009% | -3.324% | -38.429% | -33.851% | -24.109% | -36.450% |
Comments
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target lowered by analysts at HC Wainwright from $150.00 to $145.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CORT provided by MarketBeat
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target raised by analysts at Piper Sandler from $128.00 to $131.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for CORT provided by MarketBeat
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its price target raised by analysts at Truist Financial Co. from $76.00 to $150.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CORT provided by MarketBeat
News
3 Biopharmaceutical Stocks Bucking the Sell-Off
With tariffs sending markets reeling in the first days of the second quarter—the S&P 500 dropped roughly 10% in the five trading periods through Apr. 7, 2025—investors with cash to spend might be
Corcept Therapeutics Stock: Record High Fuels Analyst Optimism
Corcept Therapeutics has achieved a remarkable milestone as its stock price soared to an all-time high of $71.30, propelling the company's market capitalization to an impressive $7.4 billion. This
